Transplant medication matters for controlling cancer risk

by University of QueenslandCredit: University of QueenslandResearch reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppres

Updated on: March 08,2024

Transplant medication matters for controlling cancer risk

by University of QueenslandCredit: University of QueenslandResearch reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppres

Updated on:March 08,2024

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on: January 07,2024

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on:January 07,2024

Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors

by Arthur AllenCredit: CC0 Public DomainOn Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of shredd

Updated on: February 03,2024

Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors

by Arthur AllenCredit: CC0 Public DomainOn Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of shredd

Updated on:February 03,2024

New class of cancer mutations discovered in so-called 'junk' DNA

byGarvan Institute of Medical ResearchVisualized DNA damage (green) in human breast cancer cells (blue). Credit: Garvan InstituteUsing artificial intelligence, Garvan Institute researchers have

Updated on: July 05,2024

New class of cancer mutations discovered in so-called 'junk' DNA

byGarvan Institute of Medical ResearchVisualized DNA damage (green) in human breast cancer cells (blue). Credit: Garvan InstituteUsing artificial intelligence, Garvan Institute researchers have

Updated on:July 05,2024

Researchers identify needs of rural-based physicians to optimize cancer survivorship care

by University of MissouriCredit: Unsplash/CC0 Public DomainThe vast majority of cancer survivors rely on primary care clinicians for follow-up treatments, especially in rural areas, according to

Updated on: February 03,2024

Researchers identify needs of rural-based physicians to optimize cancer survivorship care

by University of MissouriCredit: Unsplash/CC0 Public DomainThe vast majority of cancer survivors rely on primary care clinicians for follow-up treatments, especially in rural areas, according to

Updated on:February 03,2024

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre

Updated on: January 30,2024

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre

Updated on:January 30,2024

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c

Updated on: January 29,2024

Early trial results show benefits of FGFR inhibitors and PARP/ATR inhibitor combinations in multiple tumor types

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center presented promising findings from multiple c

Updated on:January 29,2024

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t

Updated on: May 05,2024

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t

Updated on:May 05,2024

Researchers develop prostate cancer prediction tool that has unmatched accuracy

by The Mount Sinai HospitalMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A team of researchers from the Icahn Sc

Updated on: June 08,2024

Researchers develop prostate cancer prediction tool that has unmatched accuracy

by The Mount Sinai HospitalMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A team of researchers from the Icahn Sc

Updated on:June 08,2024

ASCT may offer alternative for therapy for high-risk follicular lymphoma

(HealthDay)—Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, accordin

Updated on: March 30,2024

ASCT may offer alternative for therapy for high-risk follicular lymphoma

(HealthDay)—Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, accordin

Updated on:March 30,2024

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge

Updated on: August 28,2024

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge

Updated on:August 28,2024

Branched-chain amino acids regulate the development and progression of cancer

by Agency for Science, Technology and Research (A*STAR), SingaporeFigure 1. Credit: Agency for Science, Technology and Research (A*STAR), SingaporeResearchers at A*STAR's Singapore Bioimaging

Updated on: April 14,2024

Branched-chain amino acids regulate the development and progression of cancer

by Agency for Science, Technology and Research (A*STAR), SingaporeFigure 1. Credit: Agency for Science, Technology and Research (A*STAR), SingaporeResearchers at A*STAR's Singapore Bioimaging

Updated on:April 14,2024